SonaliN(Shah)ThosaniMD
Endocrinology • Houston, TXDiabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Pediatric Endocrinology
Clinical Postdoc Fellow, Endocrinology, Baylor College of Medicine
Dr. Thosani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2012
University of Texas Health Science Center at HoustonResidency, Internal Medicine/Pediatrics, 2007 - 2010
University of Oklahoma College of MedicineInternship, Transitional Year, 2006 - 2007- University of Oklahoma College of MedicineClass of 2006
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- Join now to see all
Publications & Presentations
PubMed
- Endocrinopathies Associated With Immune Checkpoint Inhibitor Use.Anupam Kotwal, Randol Kennedy, Nupur Kikani, Sonali Thosani, Whitney Goldner
Endocrine Practice. 2024-06-01 - 1 citationsDetection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center.Jolyn S Taylor, Bryan M Fellman, Sally Raty, Javier Lasala, Maria D Iniesta
Annals of Surgical Oncology. 2024-05-01 - 4 citationsClinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center.Rebecca Jeun, Priyanka C Iyer, Conor Best, Victor Lavis, Jeena M Varghese
Immunotherapy. 2023-04-01
Press Mentions
Can Popular Weight Loss Drugs Lower Cancer Risk?November 25th, 2024- Weight Loss Injections and Cancer: 6 Questions, AnsweredNovember 11th, 2024
- Ozempic and Mounjaro May Also Lower Your Risk of Obesity-Linked CancerJuly 19th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
